BIA-ALCL: BREAST IMPLANT SAFETY UPDATE
Yesterday, the U.S. Food and Drug Administration (FDA) announced a voluntary global recall of Allergan’s BIOCELL® textured breast implants due to its risk of breast-implant associated anaplastic large cell lymphoma (BIA-ALCL), a rare form of immune system cell cancer. It’s important to note that at this time the FDA does not recommend removal of these or other …